Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT05525559 |
| Title | SHP2 Inhibitor ET0038 Monotherapy in Patients With Advanced Solid Tumors (FIRST) |
| Acronym | FIRST |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Etern BioPharma (Shanghai) Co., Ltd |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| BUMC - Mary Crowley Cancer Research Centers (MCCRC) | Dallas | Texas | 75230 | United States | Details |